- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07693465
Impact of Spinal Alignment on Pelvic Floor Efficiency
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Pelvic floor dysfunction (PFD) may extend beyond the pelvic region by inducing myofascial disturbances in anatomically distant structures connected through the myofascial network. Among these, low back pain (LBP) is one of the most frequently reported musculoskeletal conditions associated with PFD. This relationship is thought to arise from lumbopelvic instability and altered coordination of the core musculature. The pelvic floor muscles (PFMs), together with the transversus abdominis, diaphragm, and multifidus, form an integrated stabilizing system that contributes to spinal stability and postural control. Consequently, dysfunction of the transversus abdominis may compromise not only pelvic floor function but also overall lumbopelvic stability. Women with LBP have been shown to exhibit reduced PFM contraction strength despite preserved transversus abdominis activation, suggesting that impaired PFM function may play a more prominent role in the development of LBP than deficits in the abdominal muscles alone. Conversely, inadequate activation or endurance of the transversus abdominis has also been associated with impaired PFM function. Furthermore, altered movement patterns, dysfunctional breathing, and postural deviations can disrupt load transfer through the lumbopelvic region, thereby increasing the risk of PFD.
There is a dearth of knowledge regarding the effect of spinal alignment on pelvic floor efficiency in nulliparous women. This study, therefore, contributes valuable insights into a relatively unexplored area of nulliparous women's health. By assessing the pelvic floor muscles in nulliparous women with different spinal alignment patterns, including lordosis, kyphosis, and scoliosis, this study may enhance the well-being of nulliparous women, provide a more comprehensive approach to health improvement, help protect them from future pelvic floor dysfunction, and broaden the scope of physiotherapy in women's health.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
-
Giza, Egypte
- Faculty of Physical Therapy, Cairo University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
Accepte les volontaires sains
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Nulliparous women.
- Their ages will range from 25 to 35 years old.
- Their body mass index (BMI) will not exceed 29.9 Kg/m2.
Exclusion Criteria:
- Female with congenital spinal deformity.
- Female with a history of neuromuscular disease.
- Female Diagnosed with any systemic disease .
- Female with a history of malignancy and/or ongoing treatment.
- Female with a history of urogenital diseases and surgical history.
- Female with previous spinal surgery.
- Female with previous pregnancy .
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Nulliparous women with thoracolumbar scoliosis
Twenty nulliparous women with thoracolumbar scoliosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Aucune intervention
|
|
Nulliparous women with hyperlordosis
Twenty nulliparous women with hyperlordosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Aucune intervention
|
|
Nulliparous women with thoracic kyphosis
Twenty nulliparous women with thoracic kyphosis.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Aucune intervention
|
|
Nulliparous women with normal spinal alignment
Twenty nulliparous women with normal spinal alignment.
They will undergo assessment using Formetric analysis and vaginal pressure biofeedback.
|
Aucune intervention
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pelvic floor muscle strength
Délai: Baseline
|
Pelvic floor muscle strength was measured using vaginal pressure biofeedback (maximum voluntary contraction pressure).
|
Baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Pelvic floor muscle endurance
Délai: Baseline
|
Pelvic floor muscle endurance was assessed using vaginal pressure biofeedback (duration of sustained maximal voluntary contraction).
|
Baseline
|
|
Spinal alignment angle
Délai: Baseline
|
It was measured using the DIERS Formetric 4D system.
|
Baseline
|
|
Pelvic floor dysfunction symptoms
Délai: Baseline
|
Total score and domain scores (bladder, bowel, prolapse, and sexual function) were assessed using the Australian Pelvic Floor Questionnaire (APFQ).
|
Baseline
|
|
Health-related quality of life
Délai: Baseline
|
It was assessed by using Free online SF-12 Health Survey Version 2 (SF-12v2) score calculator.
The SF-12V2 measures eight scales: physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health.
|
Baseline
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chaise d'étude: Afaf Mohamed Mahmoud Botla, PhD, Professor, Cairo University
- Directeur d'études: Amira Nagy Abd Ellatief Hamad, PhD, Lecturer, Cairo University
- Directeur d'études: Amal Abd Elrahman Mohamed Elborady, Assist. Professor, Cairo University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- P.T.REC/012/005314
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .